Arcutis Biotherapeutics, Inc.
ARQTArcutis Biotherapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of topical and systemic treatments for immune-mediated dermatological diseases.
Earnings
Next report
Oct 27, 2026 (in a month)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Arcutis Biotherapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of topical and systemic treatments for immune-mediated dermatological diseases. The company leverages a drug development platform focused on validated biological targets to address unmet needs in conditions like psoriasis, atopic dermatitis, and seborrheic dermatitis. Its core value proposition lies in providing steroid-free, once-daily therapies suitable for chronic use across all body areas.
Arcutis is a leading innovator in non-steroidal topical treatments, holding a significant competitive advantage through its proprietary PDE4 inhibitor formulations and long-term patent exclusivity.
FAQ
- What is Arcutis Biotherapeutics, Inc.'s market cap?
- Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalization of $3.3B and trades on NASDAQ.
- What is Arcutis Biotherapeutics, Inc.'s revenue and profitability?
- Arcutis Biotherapeutics, Inc. generated $464.0M in trailing twelve-month revenue with a net loss of $4.8M, representing a net margin of -13.9%. Gross margin stands at 91.1%, with free cash flow of -$18.0M. The latest reported period is Q2 2026.
- Who are Arcutis Biotherapeutics, Inc.'s competitors?
- Arcutis Biotherapeutics, Inc.'s key competitors include Incyte Corporation, Amgen Inc., Pfizer Inc., and others. These companies compete in similar markets and product categories.
- Who does Arcutis Biotherapeutics, Inc. partner with?
- Arcutis Biotherapeutics, Inc.'s notable partners include Kowa Pharmaceuticals America, Inc., Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Sato Pharmaceutical Co., Ltd., and others.
- What subsidiaries does Arcutis Biotherapeutics, Inc. have?
- Arcutis Biotherapeutics, Inc.'s subsidiaries include Ducentis BioTherapeutics LTD.
- Where is Arcutis Biotherapeutics, Inc. headquartered?
- Arcutis Biotherapeutics, Inc. is headquartered in United States of America and employs approximately 296 people. It has been publicly traded since 2020.
